prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
11177,41111000001102,81115020,27902,Physiotens 200microgram tablets (Mylan),Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,9390001,,,,,,,,,0,2050200
54467,1.04491110000e+16,28325020,3,Clonidine 300micrograms/24hours transdermal patches,Clonidine,300microgram/24hour,Transdermal patch,Transdermal,Centrally Acting Antihypertensive Products,April 2013,28325020,,,,,,,,,0,2050200
63938,8099111000001101,68545020,0,Moxonidine 300microgram tablets (Sandoz Ltd),Moxonidine,300microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,August 2015,5242009,,,,,,,,,0,2050200
43989,73611000001108,98724020,1158,Aldomet 500mg tablets (Aspen Pharma Trading Ltd),Methyldopa anhydrous,500mg,Tablet,Oral,Centrally Acting Antihypertensive Products,December 2010,17999001,,,,,,,,,0,2050200
25289,5.46350010000e+16,54854020,372,Dopamet 500mg Tablet (Berk Pharmaceuticals Ltd),Methyldopa anhydrous,500mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,1707003,,,,,,,,,0,2050200
1707,318672001,59031020,330452,Methyldopa 250mg tablets,Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,2795002,,,,,,,,,0,2050200
25645,4.95550010000e+16,54232020,7,Seominal Tablet (Sterling-Winthrop),Theobromine/Phenobarbital/Reserpine,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,1545001,,,,,,,,,0,2050200
67516,3.10877110000e+16,60899021,1130,Guanfacine 2mg modified-release tablets,Guanfacine hydrochloride,2mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,September 2016,60899021,,,,,,,,,0,2050200
20690,1.39815001000e+17,66486020,193,Reserpine 250micrograms tablet,Reserpine,250micrograms,Tablets,Oral,Centrally Acting Antihypertensive Products,February 2009,4674002,,,,,,,,,0,2050200
23380,368711000001103,48571020,2054,Catapres 300microgram tablets (Boehringer Ingelheim Ltd),Clonidine hydrochloride,300microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,149002,,,,,,,,,0,2050200
9225,2.04605001000e+17,77535020,1240,Methyldopa 250mg Capsule,Methyldopa Anhydrous,250mg,Capsule,Oral,Centrally Acting Antihypertensive Products,February 2009,7905001,,,,,,,,,0,2050200
66016,3.10740110000e+16,60898021,584,Intuniv 1mg modified-release tablets (Shire Pharmaceuticals Ltd),Guanfacine hydrochloride,1mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,April 2016,60898021,,,,,,,,,0,2050200
43988,253711000001107,98722020,5400,Aldomet 250mg tablets (Aspen Pharma Trading Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,December 2010,17998001,,,,,,,,,0,2050200
71385,1.78956110000e+16,1258020,367,Aldomet 250mg tablets (Sigma Pharmaceuticals Plc),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,January 2018,1258020,,,,,,,,,0,2050200
26919,1.25025001000e+17,64553020,7,Methyldopa 50mg/ml Injection,Methyldopate Hydrochloride,50mg/ml,Injection,,Centrally Acting Antihypertensive Products,February 2009,4143002,,,,,,,,,0,2050200
10713,6855001000027101,48871020,240,Decaserpyl 5mg Tablet (Roussel Laboratories Ltd),Methoserpidine,5mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,216001,,,,,,,,,0,2050200
20656,7.65550010000e+16,57805020,421,Serpasil 250microgram Tablet (Novartis Pharmaceuticals UK Ltd),Reserpine,250microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,2447001,,,,,,,,,0,2050200
21502,1.89705001000e+17,73939020,68,Serpasil 100microgram Tablet (Novartis Pharmaceuticals UK Ltd),Reserpine,100microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,6795001,,,,,,,,,0,2050200
33322,8098911000001106,68542020,54,Moxonidine 200microgram tablets (Sandoz Ltd),Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,5241009,,,,,,,,,0,2050200
32913,874511000001106,50045020,16,Methyldopa 250mg tablets (Accord Healthcare Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,491010,,,,,,,,,0,2050200
30691,1.81845001000e+17,72628020,1,Hypercal b Tablet (Carlton Laboratories),Amobarbital Sodium/Rauwolfia DÃÂ©rivÃÂ©s,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,6418001,,,,,,,,,0,2050200
24196,5.46250010000e+16,54853020,2434,Dopamet 250mg Tablet (Berk Pharmaceuticals Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,1707002,,,,,,,,,0,2050200
73640,87911000001103,66796020,0,Methyldopa 250mg tablets (Sandoz Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,November 2018,4761009,,,,,,,,,0,2050200
58090,1.18141110000e+16,30048020,62,Clonidine 75micrograms/5ml oral solution,Clonidine hydrochloride,15microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,December 2013,30048020,,,,,,,,,2,2050200
66388,3.10746110000e+16,60902021,572,Intuniv 3mg modified-release tablets (Shire Pharmaceuticals Ltd),Guanfacine hydrochloride,3mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,June 2016,60902021,,,,,,,,,0,2050200
76479,8938711000001107,69333020,0,Moxonidine 400microgram tablets (A A H Pharmaceuticals Ltd),Moxonidine,400microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,May 2019,5463009,,,,,,,,,0,2050200
72130,1.18130110000e+16,30026020,10,Clonidine 100micrograms/5ml oral suspension,Clonidine hydrochloride,20microgram/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,May 2018,30026020,,,,,,,,,2,2050200
6694,318668000,61497020,4269,Clonidine 300microgram tablets,Clonidine hydrochloride,300microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,3367002,,,,,,,,,0,2050200
7642,665001000027102,48071020,28841,Aldomet 500mg Tablet (Merck Sharp & Dohme Ltd),Methyldopa anhydrous,500mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,24003,,,,,,,,,0,2050200
61036,2.14077110000e+16,45215020,3,Physiotens 300microgram tablets (Actavis UK Ltd),Moxonidine,300microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,September 2014,45215020,,,,,,,,,0,2050200
3049,318671008,59030020,49622,Methyldopa 125mg tablets,Methyldopa anhydrous,125mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,2795001,,,,,,,,,0,2050200
30293,364911000001108,58536020,6,Catapres 150micrograms/1ml solution for injection ampoules (Boehringer Ingelheim Ltd),Clonidine hydrochloride,150microgram/1ml,Solution for injection,Intravenous,Centrally Acting Antihypertensive Products,February 2009,2662001,,,,,,,,,0,2050200
66429,3.10749110000e+16,60904021,660,Intuniv 4mg modified-release tablets (Shire Pharmaceuticals Ltd),Guanfacine hydrochloride,4mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,June 2016,60904021,,,,,,,,,0,2050200
29187,1.24475001000e+17,64496020,46,Methoserpidine 10mg Tablet,Methoserpidine,10mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,4128002,,,,,,,,,0,2050200
55797,8398311000001106,19530020,49,Clonidine 25micrograms/5ml oral solution,Clonidine hydrochloride,5microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,June 2013,19530020,,,,,,,,,2,2050200
41661,1.59650010000e+16,50040020,18,Methyldopa 250mg Tablet (C P Pharmaceuticals Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,March 2010,490010,,,,,,,,,0,2050200
21346,1.25115001000e+17,64564020,1490,Hydromet Tablet (MSD Thomas Morson Pharmaceuticals),Hydrochlorothiazide/Methyldopa Anhydrous,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,4146001,,,,,,,,,0,2050200
71110,1.78958110000e+16,1265020,25,Aldomet 500mg tablets (Sigma Pharmaceuticals Plc),Methyldopa anhydrous,500mg,Tablet,Oral,Centrally Acting Antihypertensive Products,December 2017,1265020,,,,,,,,,0,2050200
7416,5.11650010000e+16,54406020,12,Aldomet 50mg/ml Injection (Merck Sharp & Dohme Ltd),Methyldopate Hydrochloride,50mg/ml,Injection,Intravenous Injection,Centrally Acting Antihypertensive Products,February 2009,1594001,,,,,,,,,0,2050200
14390,5.11450010000e+16,54403020,472,Aldomet 250mg/5ml Liquid (Merck Sharp & Dohme Ltd),Methyldopa anhydrous,50mg/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products,February 2009,1593001,,,,,,,,,0,2050200
19892,7.65750010000e+16,57809020,944,Serpasil -esidrex Tablet (Novartis Pharmaceuticals UK Ltd),Hydrochlorothiazide/Reserpine,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,2448001,,,,,,,,,0,2050200
29570,5.46150010000e+16,54852020,265,Dopamet 125mg Tablet (Berk Pharmaceuticals Ltd),Methyldopa anhydrous,125mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,1707001,,,,,,,,,0,2050200
60136,1.18129110000e+16,30024020,15,Clonidine 100micrograms/5ml oral solution,Clonidine hydrochloride,20microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,June 2014,30024020,,,,,,,,,2,2050200
67005,3.10876110000e+16,60897021,1126,Guanfacine 1mg modified-release tablets,Guanfacine hydrochloride,1mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,August 2016,60897021,,,,,,,,,0,2050200
78943,3.64664110000e+16,83194021,0,Clonidine 50micrograms/5ml oral solution sugar free (A A H Pharmaceuticals Ltd),Clonidine hydrochloride,10microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,December 2019,83194021,,,,,,,,,2,2050200
68529,3.10878110000e+16,60901021,944,Guanfacine 3mg modified-release tablets,Guanfacine hydrochloride,3mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,January 2017,60901021,,,,,,,,,0,2050200
15493,1.39855001000e+17,66489020,1,Reserpine with hydrochlorothiazide tablet,Hydrochlorothiazide/Reserpine,,Tablets,Oral,Centrally Acting Antihypertensive Products,February 2009,4675001,,,,,,,,,0,2050200
4215,215111000001101,48570020,14570,Catapres 100microgram tablets (Boehringer Ingelheim Ltd),Clonidine hydrochloride,100microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,149001,,,,,,,,,0,2050200
40310,8390411000001102,69037020,95,Moxonidine 200microgram tablets (Teva UK Ltd),Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,September 2009,5383009,,,,,,,,,0,2050200
10714,1.24465001000e+17,64495020,4,Methoserpidine 5mg Tablet,Methoserpidine,5mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,4128001,,,,,,,,,0,2050200
43531,8099411000001106,68547020,91,Moxonidine 400microgram tablets (Sandoz Ltd),Moxonidine,400microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,September 2010,5243009,,,,,,,,,0,2050200
16248,3.60892110000e+16,61500020,359,Clonidine 150micrograms/1ml solution for injection ampoules,Clonidine hydrochloride,150microgram/1ml,Solution for injection,Intravenous,Centrally Acting Antihypertensive Products,February 2009,3368001,,,,,,,,,0,2050200
76766,1.04493110000e+16,28326020,1,Catapres TTS 3 patches (Imported (Germany)),Clonidine,300microgram/24hour,Transdermal patch,Transdermal,Centrally Acting Antihypertensive Products,July 2019,28326020,,,,,,,,,0,2050200
29696,1.24515001000e+17,64499020,5,Methoserpidine with benzthiazide Tablet,Benzthiazide/Methoserpidine,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,4129001,,,,,,,,,0,2050200
67808,2.14062110000e+16,45147020,35,Physiotens 200microgram tablets (Actavis UK Ltd),Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,October 2016,45147020,,,,,,,,,0,2050200
74534,3.23920110000e+16,65956021,1,Clonidine 250micrograms/5ml oral suspension,Clonidine hydrochloride,50microgram/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,January 2019,65956021,,,,,,,,,2,2050200
25393,6865001000027105,48872020,88,Decaserpyl 10mg Tablet (Roussel Laboratories Ltd),Methoserpidine,10mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,216002,,,,,,,,,0,2050200
8033,645001000027108,48069020,14025,Aldomet 125mg Tablet (Merck Sharp & Dohme Ltd),Methyldopa anhydrous,125mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,24001,,,,,,,,,0,2050200
67200,8397911000001106,19522020,2,Clonidine 10micrograms/5ml oral solution,Clonidine hydrochloride,2microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,August 2016,19522020,,,,,,,,,2,2050200
66936,3.10743110000e+16,60900021,699,Intuniv 2mg modified-release tablets (Shire Pharmaceuticals Ltd),Guanfacine hydrochloride,2mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,July 2016,60900021,,,,,,,,,0,2050200
4993,318707000,81108020,463369,Moxonidine 200microgram tablets,Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,9386001,,,,,,,,,0,2050200
58529,7660211000001104,18103020,76,Clonidine 200micrograms/24hours transdermal patches,Clonidine,200microgram/24hour,Transdermal patch,Transdermal,Centrally Acting Antihypertensive Products,January 2014,18103020,,,,,,,,,0,2050200
60898,8171411000001109,69282020,0,Moxonidine 200microgram tablets (Mylan),Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,August 2014,5450009,,,,,,,,,0,2050200
2878,318667005,61496020,65344,Clonidine 100microgram tablets,Clonidine hydrochloride,100microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,3367001,,,,,,,,,0,2050200
18252,2.96950010000e+16,51708020,1567,Metalpha 250mg Tablet (Ashbourne Pharmaceuticals Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,May 2019,897001,,,,,,,,,0,2050200
52555,8398511000001100,19534020,311,Clonidine 50micrograms/5ml oral solution,Clonidine hydrochloride,10microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,January 2013,19534020,,,,,,,,,2,2050200
62853,8936111000001107,69326020,0,Moxonidine 200microgram tablets (A A H Pharmaceuticals Ltd),Moxonidine,200microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,April 2015,5461009,,,,,,,,,0,2050200
67675,3.10879110000e+16,60903021,1178,Guanfacine 4mg modified-release tablets,Guanfacine hydrochloride,4mg,Modified-release tablet,Oral,Centrally Acting Antihypertensive Products,September 2016,60903021,,,,,,,,,0,2050200
49684,1.04485110000e+16,28322020,80,Clonidine 100micrograms/24hours transdermal patches,Clonidine,100microgram/24hour,Transdermal patch,Transdermal,Centrally Acting Antihypertensive Products,January 2013,28322020,,,,,,,,,0,2050200
61710,1.84028110000e+16,77911020,0,Clonidine 25microgram tablets (Teva UK Ltd),Clonidine hydrochloride,25microgram,Tablet,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,November 2014,8030009,,,,,,,,,2,2050200
78159,4.29250010000e+16,53399020,168,Methyldopa 250mg Tablet (Approved Prescription Services Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,October 2019,1334010,,,,,,,,,0,2050200
72807,1.18133110000e+16,30032020,3,Clonidine 15micrograms/5ml oral solution,Clonidine hydrochloride,3microgram/1ml,Oral solution,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,August 2018,30032020,,,,,,,,,2,2050200
3070,318673006,59032020,108288,Methyldopa 500mg tablets,Methyldopa anhydrous,500mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,2795003,,,,,,,,,0,2050200
62513,1.72042110000e+16,66587020,11,Methyldopa 250mg tablets (Sovereign Medical Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,March 2015,4702009,,,,,,,,,0,2050200
78897,2.43897110000e+16,23671021,0,Methyldopa 250mg tablets (Bristol Laboratories Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,November 2019,23671021,,,,,,,,,0,2050200
9876,522011000001109,81117020,2815,Physiotens 300microgram tablets (Mylan),Moxonidine,300microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,9390003,,,,,,,,,0,2050200
9749,142811000001107,81116020,13381,Physiotens 400microgram tablets (Mylan),Moxonidine,400microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,9390002,,,,,,,,,0,2050200
78157,1.59550010000e+16,50039020,116,Methyldopa 125mg Tablet (C P Pharmaceuticals Ltd),Methyldopa anhydrous,125mg,Tablet,Oral,Centrally Acting Antihypertensive Products,October 2019,490009,,,,,,,,,0,2050200
77591,8398211000001103,19528020,18,Clonidine 12.5micrograms/5ml oral suspension,Clonidine hydrochloride,2.5microgram/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,August 2019,19528020,,,,,,,,,2,2050200
72819,1.79409110000e+16,1259020,0,Methyldopa 250mg tablets (Phoenix Healthcare Distribution Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,August 2018,1259020,,,,,,,,,0,2050200
78162,88511000001109,50046020,168,Methyldopa 125mg tablets (Actavis UK Ltd),Methyldopa anhydrous,125mg,Tablet,Oral,Centrally Acting Antihypertensive Products,October 2019,491011,,,,,,,,,0,2050200
28738,1.25055001000e+17,64556020,92,Methyldopa with hydrochlorothiazide Tablet,Hydrochlorothiazide/Methyldopa Anhydrous,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,4144001,,,,,,,,,0,2050200
7626,655001000027106,48070020,132427,Aldomet 250mg Tablet (Merck Sharp & Dohme Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,24002,,,,,,,,,0,2050200
22853,1.39805001000e+17,66485020,28,Reserpine 100micrograms tablet,Reserpine,100micrograms,Tablets,Oral,Centrally Acting Antihypertensive Products,February 2009,4674001,,,,,,,,,0,2050200
25275,2.97050010000e+16,51709020,407,Metalpha 500mg Tablet (Ashbourne Pharmaceuticals Ltd),Methyldopa anhydrous,500mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,897002,,,,,,,,,0,2050200
23761,8667311000001100,64552020,764,Methyldopa 250mg/5ml oral suspension,Methyldopa anhydrous,50mg/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products,February 2009,4143001,,,,,,,,,0,2050200
77825,233711000001108,50055020,0,Methyldopa 250mg tablets (A A H Pharmaceuticals Ltd),Methyldopa anhydrous,250mg,Tablet,Oral,Centrally Acting Antihypertensive Products,August 2019,493010,,,,,,,,,0,2050200
53142,8398611000001101,19536020,139,Clonidine 50micrograms/5ml oral suspension,Clonidine hydrochloride,10microgram/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,January 2013,19536020,,,,,,,,,2,2050200
67665,8265311000001105,68995020,0,Moxonidine 400microgram tablets (Actavis UK Ltd),Moxonidine,400microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,September 2016,5370009,,,,,,,,,0,2050200
2104,2.67250010000e+16,51347020,85,Rauwiloid 2mg Tablet (3M Health Care Ltd),Alseroxylon,2mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,807001,,,,,,,,,0,2050200
10253,408604009,81110020,137326,Moxonidine 300microgram tablets,Moxonidine,300microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,9386003,,,,,,,,,0,2050200
30129,45001000027103,47989020,3,Abicol Tablet (Knoll Ltd),Bendroflumethiazide/Reserpine,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,3001,,,,,,,,,0,2050200
4406,4.84650010000e+16,54101020,258,Decaserpyl plus Tablet (Roussel Laboratories Ltd),Benzthiazide/Methoserpidine,,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,1511001,,,,,,,,,0,2050200
7174,318708005,81109020,239709,Moxonidine 400microgram tablets,Moxonidine,400microgram,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,9386002,,,,,,,,,0,2050200
23345,1.39675001000e+17,66471020,9,Hypercal 2mg Tablet (Carlton Laboratories),Alseroxylon,2mg,Tablet,Oral,Centrally Acting Antihypertensive Products,February 2009,4670001,,,,,,,,,0,2050200
61256,8426311000001108,19543020,1,Clonidine 5micrograms/5ml oral suspension,Clonidine hydrochloride,1microgram/1ml,Oral suspension,Oral,Centrally Acting Antihypertensive Products/Prophylaxis Of Migraine/Oestrogens And HRT,September 2014,19543020,,,,,,,,,2,2050200
